As this challenging year comes to a close, we would like to thank all of our colleagues for their steadfast support of minority health. Your work has continued important conversations about health equity on a local and national stage. |
|
NMH Alliance's Year in Review |
|
This newsletter contains an overview of the work of the NMH Alliance in 2021. We would like to thank our Board Members, Steering Committee, partners, sponsors, and staff for their hard work in advancing the mission and goals of the NMH Alliance. |
|
You may have noticed that we changed our name from the 'National Minority Cardiovascular Alliance' to the 'National Minority Health Alliance.' Given that risk factors for CVD, as well as other diseases that substantially impact underserved minority populations (such as cancer and diabetes) are the same, we feel that a slight shift in the focus of the Alliance will enable the organization to better support our constituents.
Thank you to our current partners for your continued support of the Alliance, and we look forward to building new relationships as we continue this important work together!
|
|
Ancillary Study of Latinos (SOL) |
|
Our ancillary study within the NHLBI Hispanic Community Health Study/Study of Latinos - in order to better understand biomarkers specific to dyslipidemia in Hispanic/Latino sub-group populations - is wrapping up. We look forward to sharing our findings at our poster presentation at ACC 2022. |
Master Class on Dyslipidemia |
In 2020, we developed and launched a Master Class on Dyslipidemia to support communication about this condition between clinicians and minority patients. In 2021, the NMH Alliance was funded to expand the program by holding additional focus groups to obtain information with an expanded group of patients and taking a deeper dive into our findings. Stay tuned for the results very soon!
Visit our website for more information, and be sure to reach out if you'd like to host a free training for your organization.
|
|
This year, the NMH Alliance writing committee had our first article published. Read "Could Clinician Sensitivity to Cultural and Historical Considerations Help Reduce COVID-19 Deaths among Blacks?" HERE
|
|
eCARDIO Hub (electronic Clearinghouse for Articles, Research, Data, Insights and Outcomes) continues to grow. This free resource has updated research and data regarding minority cardiovascular health, including news and research on COVID-19's impact on minority health. We encourage you to share this resource with your colleagues and organizations and submit your information for inclusion. For more information, please see below. |
|
2021 Annual Meeting and Town Hall |
|
Although we could not gather in person again this year, we were still able to have robust conversations, meetings, and events virtually. Our annual Steering Committee Meeting offered the opportunity for members to come together and discuss the current strengths and challenges facing minority cardiovascular health. The Committee outlined Alliance activities and priorities for the coming year.
Our 4th Annual Town Hall was split into two thought-provoking events this year.
Agendas below and link to recordings HERE.
|
|
Advocacy Corner
The NMH Alliance has partnered with the Partnership to Advance Cardiovascular Health (PACH) to address the unsafe practice of non-medical switching.
Beginning in 2022, CVS Caremark will remove all but one direct oral anticoagulant (DOAC) from its commercial pharmacy benefit plan. This formulary change disrupts stable medical management of patients who are at high risk of stroke and other thromboembolic cardiovascular events. To address this access barrier, PACH has submitted a letter to CVS to strongly urge them to continue DOAC coverage for patients who are already well-managed on their current medication prescribed by their clinician.
Help us let insurers know changes to treatment must be a joint decision between patients and providers, not health plans and their profits.
|
|
The NMH Alliance is looking forward to launching a new program in 2022, the Community Leader Engagement Program. Keep an eye out for more details coming soon.
|
|
Make Well Known Foundation is grateful for the unrestricted support of our sponsors Amgen, Esperion, Janssen, Novartis, and Pfizer to make the Alliance initiatives possible. |
|
Connect with us on social media! |
|
National Minority Health Alliance | Website
|
|
Together, we are working to better understand the similarities and uniquenesses of genetics, culture, and socioeconomic status, in order to prevent, diagnose, and treat disease and manage the health of African American, Hispanic/Latino, Asian/Pacific Islander and Native American populations.
|
|
|
|
|
|
|
